Ureteral Stent Encrustation: Epidemiology, Pathophysiology, Management and Current Technology. Reply.

No AccessJournal of UrologyLetters to the Editor1 Jan 2022Ureteral Stent Encrustation: Epidemiology, Pathophysiology, Management and Current Technology. Reply.is a reply to letterUreteral Stent Encrustation: Epidemiology, Pathophysiology, Management and Current Technology. Letter. Nir Tomer, Evan Garden, Alexander Small, and Michael Palese Nir TomerNir Tomer Department of Urology, Icahn School of Medicine at Mount Sinai, New York, New York More articles by this author , Evan GardenEvan Garden Department of Urology, Icahn School of Medicine at Mount Sinai, New York, New York More articles by this author , Alexander SmallAlexander Small Department of Urology, Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, New York More articles by this author , and Michael PaleseMichael Palese † E-mail Address: [email protected] Department of Urology, Icahn School of Medicine at Mount Sinai, New York, New York More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000001679AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail References 1. : Ureteral stent encrustation: epidemiology, pathophysiology, management and current technology. J Urol 2021; 205: 68. Link, Google Scholar 2. : Healthcare IT market by product type (healthcare provider solutions, healthcare payer solutions, and HCIT outsourcing services) and end user (healthcare providers and healthcare payers): U.S. opportunity analysis and industry forecast, 2017–2025. Available at https://www.marketresearch.com/BIS-Research-v4011/Healthcare-Product-Type-Provider-Solutions-12862331/. Google Scholar 3. : Preventing the forgotten ureteral stent: implementation of a web-based stent registry with automatic recall application. Urology 2007; 70: 423. Google Scholar 4. : Preventing the forgotten ureteral stent by using a mobile point-of-care application. J Endourol 2017; 31: 719. Google Scholar 5. : Pushing stones uphill: why patients are lost to follow-up after uncomplicated ureteroscopy. J Endourol 2017; 31: 135. Google Scholar 6. : Reduction of ureteral stent encrustation by modulating the urine pH and inhibiting the crystal film with a new oral composition: a multicenter, placebo controlled, double blind, randomized clinical trial. BMC Urol 2020; 20: 65. Google Scholar © 2021 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetailsRelated articlesJournal of Urology16 Feb 2021Ureteral Stent Encrustation: Epidemiology, Pathophysiology, Management and Current Technology. Letter. Volume 207Issue 1January 2022Page: 249-250 Advertisement Copyright & Permissions© 2021 by American Urological Association Education and Research, Inc.MetricsAuthor Information Nir Tomer Department of Urology, Icahn School of Medicine at Mount Sinai, New York, New York More articles by this author Evan Garden Department of Urology, Icahn School of Medicine at Mount Sinai, New York, New York More articles by this author Alexander Small Department of Urology, Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, New York More articles by this author Michael Palese Department of Urology, Icahn School of Medicine at Mount Sinai, New York, New York † E-mail Address: [email protected] More articles by this author Expand All Advertisement PDF downloadLoading ...